Oncogene-mediated transformation results in the disruption of normal cellular growth-control. Understanding the role normal counterparts of transforming agents play in cellular homeostasis will enhance our ability to decipher the molecular mechanisms by which oncogenic agents cause this system to go awry. Our studies have provided two lines of evidence which suggest that the proto- oncogene product, pp60c-src, is involved in the mitogenic response of cells to epidermal growth factor (EGF). First, murine C3H10T1/2 fibroblasts constitutively overexpressing pp60c-src exhibit a hyper-responsiveness to EGF (as measured by 3H- thymidine incorporation) when compared to the response of stimulated, parent cells. Second, a dramatic negative regulation of pp60c-src specific kinase activity occurs in quail embryo fibroblasts transformed by the avian erythroblastosis virus (AEV), which encodes aberrant forms of the thyroxin receptor (v-erb A) and the EGF receptor (v-erb B). The experiments outlines in this proposal have two inter-related aims. The first is to determine the molecular mechanism for the enhanced responsiveness of c- src overexpressors to EGF by analyzing and comparing levels of second messengers, critical protein kinases and expression of proto-oncogenes in mitogen-stimulated parent and overexpressor lines. Analysis of cells overexpressing c-src bearing site-directed mutations in the molecule and microinjection of monoclonal antibodies with specificities to defined epitopes will be carried out to determine regions within the c-src protein which are required for the interaction with cellular components that result in the enhanced response to growth factors.
The second aim i s to determine the mechanism of down-modulation of pp60c-src activity in AEV infected cells. A genetic approach utilizing deletion and temperature-sensitive mutants of AEV will allow us to determine whether v-erb A or v-erb B or both are required for this effect. Intracellular localization studies, analysis of signal transduction components, and purification and identification of cellular agents which mediate the regulatory effects on pp60c-src in uninfected and wild type and mutant infected AEV cells are also proposed. Together these studies have as their common goal the elucidation of the temporal and spatial relationships of pp60c- src to substrate and regulatory components of the EGF-dependent signal transduction pathway(s).

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Virginia
Schools of Medicine
United States
Zip Code
Manukyan, Arkadi; Ludwig, Kirsten; Sanchez-Manchinelly, Sergio et al. (2015) A complex of p190RhoGAP-A and anillin modulates RhoA-GTP and the cytokinetic furrow in human cells. J Cell Sci 128:50-60
Manchinelly, Sergio A Sánchez; Miller, Joyce Agati; Su, Ling et al. (2010) Mitotic down-regulation of p190RhoGAP is required for the successful completion of cytokinesis. J Biol Chem 285:26923-32
Su, Ling; Pertz, Olivier; Mikawa, Masahito et al. (2009) p190RhoGAP negatively regulates Rho activity at the cleavage furrow of mitotic cells. Exp Cell Res 315:1347-59
Mikawa, Masahito; Su, Ling; Parsons, Sarah J (2008) Opposing roles of p190RhoGAP and Ect2 RhoGEF in regulating cytokinesis. Cell Cycle 7:2003-12
Su, Ling; Agati, Joyce M; Parsons, Sarah J (2003) p190RhoGAP is cell cycle regulated and affects cytokinesis. J Cell Biol 163:571-82
Kloth, Michael T; Laughlin, Kristen K; Biscardi, Jacqueline S et al. (2003) STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor. J Biol Chem 278:1671-9
Haskell, M D; Slack, J K; Parsons, J T et al. (2001) c-Src tyrosine phosphorylation of epidermal growth factor receptor, P190 RhoGAP, and focal adhesion kinase regulates diverse cellular processes. Chem Rev 101:2425-40
Haskell, M D; Nickles, A L; Agati, J M et al. (2001) Phosphorylation of p190 on Tyr1105 by c-Src is necessary but not sufficient for EGF-induced actin disassembly in C3H10T1/2 fibroblasts. J Cell Sci 114:1699-708
Biscardi, J S; Ishizawar, R C; Silva, C M et al. (2000) Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer. Breast Cancer Res 2:203-10
Roof, R W; Dukes, B D; Chang, J H et al. (2000) Phosphorylation of the p190 RhoGAP N-terminal domain by c-Src results in a loss of GTP binding activity. FEBS Lett 472:117-21

Showing the most recent 10 out of 35 publications